Comparative permeability of human vaginal and buccal mucosa to water

European Journal of Oral Sciences

Volumn 105, Issue 6, 1997, Pages 571-575

  Van Der Bijl, Pieter ^a   Thompson, Ivor O C ^a   Squier, Christopher A ^b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Human vaginal and buccal mucosa; Permeability of water

Indexed keywords

DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; TRITIUM; WATER;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BIOPSY; COMPARATIVE STUDY; CONNECTIVE TISSUE; DIFFUSION; DIFFUSION CHAMBER; EPITHELIUM; FEMALE; HISTOLOGY; HUMAN; HYSTERECTOMY; MALE; METABOLISM; MIDDLE AGED; MOUTH MUCOSA; MUCOSA; ORAL SURGERY; PERMEABILITY; PHARMACOKINETICS; VAGINA;

ADULT; ANALYSIS OF VARIANCE; BIOPSY; CONNECTIVE TISSUE; DIFFUSION; DIFFUSION CHAMBERS, CULTURE; EPITHELIUM; FEMALE; HUMANS; HYSTERECTOMY; MALE; MIDDLE AGED; MOUTH MUCOSA; MUCOUS MEMBRANE; ORAL SURGICAL PROCEDURES; PERMEABILITY; PHARMACOKINETICS; RADIOPHARMACEUTICALS; TRITIUM; VAGINA; WATER;

EID: 0031308372     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1111/j.1600-0722.1997.tb00219.x     Document Type: Review

References (21)

1. LESCH CA, SQUIER CA, CRUCHLEY A, WILLIAMS DM, SPEIGHT P. The permeability of human oral mucosa and skin to water. J Dent Res 1989; 68: 1345-1349.
2. ZAINO RJ, ROBBOY SJ, BENTLEY R, KURMAN RJ. Diseases of the vagina. In: KURMAN R (ed). Blaustein's pathology of the female genital tract; 4th edition. New York, NJ: Springer-Verlag, 1994; 131-136.
3. WERTZ PW, SWARTZENDRUBER DC, SQUIER CA. Regional variation in the structure and permeability of oral mucosa and skin. Adv Drug Deliv Rev 1993; 12: 1-12.
4. MURRELL W. Nitroglycerine as a remedy for angina pectoris. Lancet 1879; i: 225.
5. VAN DER BIJL P, ROELOFSE JA, JOUBERT JJ DE V. Comparison of sublingual lorazepam with intramuscular diazepam as sedatives during oral surgery. J Oral Maxillofac Surg 1988; 46: 559-568.
6. HARRIS D, ROBINSON JR. Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci 1992; 81: 1-10.
7. SAYANI AP, CHUN IK, CHIEN YW. Transmucosal delivery of leucine enkephalin: Stabilization in rabbit enzyme extracts and enhancement of permeation through mucosae. J Pharm Sci 1993; 82: 1179-1185.
8. HENRIKSSON L, STJERNQUIST M, BOQUIST L, CEDERGREN I, SELInUS I. A one-year multicenter study of efficacy and safety of a continuous low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging. Am J Obstet Gynecol 1996; 174: 85-92.
9. COUTINHO EM, O'DWYER E, BARBOSA IC, GU ZP, SHAABAN MM, ABOUL-OYOON M, ABDEL ALEEM H. Comparative study on intermittent versus continuous use of a contraceptive pill administered by vaginal route. Contraception 1995; 51: 355-358.
10. ARCHER DF, FAHY GE, VINIEGRA-SIBAL A, ANDERSON FD, SNIPES W, FOLDESY RG. Initial and steady-state pharmacokinetics of a vaginally administered formulation of progesterone. Am J Obstet Gynecol 1995; 173: 471-477.
11. NILSSON K, HEIMER G. Low-dose 17-beta-oestradiol during maintenance therapy - a pharmacokinetic and pharmacodynamic study. Maturitas 1995; 21: 33-38.
12. CREININ MD, VITTINGHOFF E, GALBRAITH S, KLAISLE C. A randomized trial comparing misoprostol three and seven days after methotrexate for early abortion. Am J Obstet Gynecol 1995; 173: 1578-1584.
13. CHUCK FJ, HUFFAKER BJ. Labor induction with intravaginal misoprostol versus intracervical prostaglandin E2 gel (Prepidil gel) : randomized comparison. Am J Obstet Gynecol 1995; 173: 1137-1142.
14. VARAKLIS K, GUMINA R, STUBBLEFIELD PG. Randomized controlled trial of vaginal misoprostol and intracervical prostaglandin E2 gel for induction of labor at term. Obstet Gynecol 1995; 86: 541-544.
15. HINSHAW K, EL-REFAEY H, RISPIN R, TEMPLETON A. Midtrimester termination for fetal abnormality : advantages of a new regimen using mifepristone and misoprostol. Br J Obstet Gynaecol 1995; 102: 559-560.
16. DOWTY ME, KNUTH KE, IRONS BK, ROBINSON JR. Transport of thyrotropin releasing hormone (TRH) in rabbit buccal mucosa in vitro. Pharm Res 1992; 9: 1113-1122.
17. SQUIER CA, KREMER M, WERTZ PW. Continuous flow mucosal cells for measuring the in vitro permeability of small tissue samples. J Pharm Sci 1997; 86: 82-84.
18. SQUIER CA, WERTZ PW, WILLIAMS DM, CRUCHLEY AT. Permeability of oral mucosa and skin with age. In: SQUIER CA, HILL MW (eds): The effect of aging in oral mucosa and skin. Boca Raton, FL: CRC Press, 1994; 91-98.
19. SQUIER CA, HILL MW. Oral mucosa. In: TEN CATE AR (ed): Oral histology, development, structure and function. St. Louis, MO: C.V. Mosby, 1989; 341-385.
20. HWANG S, OWADA E, YOTSNYANAGI T, SUHARDJA NFH, Ho G, FLYNN GL, HIGUCHI WI. Systems approach to vaginal delivery of drugs II : in situ vaginal absorption of unbranched aliphatic alcohols. J Pharm Sci 1976; 65: 1574-1578.
21. WINTERHAGER E, KUHNEL W. Diffusion barriers in the vaginal epithelium during the estrous cycle in guinea pigs. Cell Tissue Res 1985; 241: 325-331.